Understanding HoLEP - Advances in Prostate Treatment - Dr Jeevagan Murugesan

Published Date: 01 Mar 2023

Benign prostatic hyperplasia (BPH) is a condition in which the prostate gland enlarges, causing problems or obstruction in urination...

Read Full News

Latest News

This Test Could Predict Incontinence Risk After HoLEP

Men with a shorter membranous urethra appear more likely to experience urinary incontinence after laser enucleation for benign prostatic hyperplasia, a new study shows.

Smartphone App Helps Delay Ejaculation

The app improves sexual control and doubles ejaculation latency time in a randomized trial.

US FDA Approves Lantheus' New Prostate Cancer Imaging Formulation

The U.S. Food and Drug Administration on Friday approved a new formulation of Lantheus Holdings' prostate ⁠cancer imaging agent, aimed at improving scanning access through...

Will a Smart Toilet Turn the Home Into a Diagnostic Center?

Smart toilets show promise for passive monitoring of stool and urine to detect potential health issues, but challenges remain.

Bayer Sues Johnson & Johnson Over Claim That Prostate Cancer Drug Cuts Risk Of Death

Bayer sued Johnson & Johnson on Monday, accusing the drugmaker of falsely advertising that its rival multibillion-dollar drug cuts the ⁠risk of death from prostate...

Doc Murdered 8 Patients? RFK Jr. Will 'Cost Lives'; $412M in Penile Injection Case

Health news and commentary gathered by MedPage Today staff

Todays Updates

Gotistobart Response Rate Bests Chemo in Pretreated NSCLC

Previously treated patients with NSCLC respond to anti-CTLA-4 therapy.

Todays Updates

Gotistobart Response Rate Bests Chemo in Pretreated NSCLC

Previously treated patients with NSCLC respond to anti-CTLA-4 therapy.

Latest News

Men with a shorter membranous urethra appear more likely to experience urinary incontinence after laser enucleation for benign prostatic hyperplasia, a new study shows.

The app improves sexual control and doubles ejaculation latency time in a randomized trial.

The U.S. Food and Drug Administration on Friday approved a new formulation of Lantheus Holdings' prostate ⁠cancer imaging agent, aimed at improving scanning access through...

Smart toilets show promise for passive monitoring of stool and urine to detect potential health issues, but challenges remain.

Bayer sued Johnson & Johnson on Monday, accusing the drugmaker of falsely advertising that its rival multibillion-dollar drug cuts the ⁠risk of death from prostate...

Health news and commentary gathered by MedPage Today staff

News All Time

King Charles III's Operation; COVID-19 Timeline Under Question; FDA Approvals Reach Record High.

The staff of MedPage Today has compiled health news and commentary from around the web.

Noninvasive Treatment Effective in Bladder Cancer That Is Not Muscle-Invasive.

An investigational intrusive solution produced a 79% complete response rate.

For Prostate Cancer at Intermediate Risk, SBRT Is Not Less Effective Than Conventional RT.

Similar results are obtained from treatment lasting one to two weeks as compared to therapy lasting up to seven and a half weeks.

Even in those with HIV, a single dose of antibiotics was able to cure early syphilis.

In a randomized trial, one dosage showed no worse results than a triple-dose regimen.

Should Patients With Advanced Prostate Cancer Get Off the Active Surveillance Train?

Clearly defined rules are needed.

The new first-line standard for advanced bladder cancer was produced by a landmark trial.

When compared to chemotherapy, enfortumab vedotin-pembrolizumab doubles OS and PFS.

An RCT Supports HIF-2a Inhibition in Advanced RCC.

Belzutifan outperforms everolimus in the event of immunotherapy-TKI failure.

AR-Pathway Inhibitor Switch for mCRPC is Superseded by Radionuclide Therapy.

With 177Lu-PSMA-617, the time to radiographic progression was doubled.

Cabazitaxel Lower-Dose Schedule Is Viable for Elderly Patients With mCRPC.

Neutropenia of grade three or above, with a twelve-fold reduction in neutropenic consequences.

Removing Cancer Survivors From Oncologic Treatment.

A new approach to care is required.

In severe cases of renal cell carcinoma, tyrosine kinase inhibitor activity is present.

Reactions to the "special medication" zanzalintinib in patients exposed and not exposed to cabozantinib.

Finding New Routes to Improve Renal Cell Carcinoma Outcomes.

It is necessary to intervene at several stages of the cancer immunity cycle in order to build on recent successes.

CAR T-Cell Therapy for Renal Cell Carcinoma: "We're Not There Yet".

Possibility of standard of care following current therapies, but significant barriers still need to be overcome.

Dietary inflammation is associated with the development of urologic cancers.

In health research, the relationship between dietary habits and cancer risks is still a major focus. The has been the subject of a recent meta-analysis.

In infants, laparoscopic robotic pyeloplasty is safe and has a success rate comparable to open surgery.

The results of minimally invasive pyeloplasty (MIP) for the primary cause, ureteropelvic junction obstruction (UPJO), were examined in a recent study.

Medical Bulletin November 30, 2023.

The top medical stories of the day are as follows: ADHD increases the risk of car crashes in older adults. ADHD is a neurodevelopmental disorder that is chronic and has symptoms.

Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients

Prostate cancer death risk is higher in late teens and early 20s weight gain.

Participate and win cash vouchers

Get updates on the latest events happening around the world

2.

'It's rare and it's scary.' Dark spot on your fingernail could mean cancer

3.

Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer

4.

Experts say oncology, primary care coordination necessary for best cancer patient outcomes

5.

How a California Oncologist Making $850k Spends Money

1.

Tazemetostat: A Promising New Treatment for Cancer

2.

The Converging Frontiers of Radiation Oncology and Systemic Therapies by 2025

3.

Advancing Cancer Trials: Integrating Master Protocols and Immunotherapy Guidelines

4.

Unlocking the Potential of Trabectedin: A Novel Therapy for Cancer Treatment

5.

Unlocking the Potential of Lymphocytes: Exploring the Role of These Immune System Cells

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Cost Burden/ Burden of Hospitalization For R/R ALL Patients

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I

3.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia

4.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

5.

Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Understanding HoLEP - Advances in Prostate Treatment - Dr Jeevagan Murugesan

Latest News

This Test Could Predict Incontinence Risk After HoLEP

Smartphone App Helps Delay Ejaculation

US FDA Approves Lantheus' New Prostate Cancer Imaging Formulation

Will a Smart Toilet Turn the Home Into a Diagnostic Center?

Bayer Sues Johnson & Johnson Over Claim That Prostate Cancer Drug Cuts Risk Of Death

Doc Murdered 8 Patients? RFK Jr. Will 'Cost Lives'; $412M in Penile Injection Case

Todays Updates

Gotistobart Response Rate Bests Chemo in Pretreated NSCLC

Todays Updates

Gotistobart Response Rate Bests Chemo in Pretreated NSCLC

Latest News

News All Time

King Charles III's Operation; COVID-19 Timeline Under Question; FDA Approvals Reach Record High.

Noninvasive Treatment Effective in Bladder Cancer That Is Not Muscle-Invasive.

For Prostate Cancer at Intermediate Risk, SBRT Is Not Less Effective Than Conventional RT.

Even in those with HIV, a single dose of antibiotics was able to cure early syphilis.

Should Patients With Advanced Prostate Cancer Get Off the Active Surveillance Train?

The new first-line standard for advanced bladder cancer was produced by a landmark trial.

An RCT Supports HIF-2a Inhibition in Advanced RCC.

AR-Pathway Inhibitor Switch for mCRPC is Superseded by Radionuclide Therapy.

Cabazitaxel Lower-Dose Schedule Is Viable for Elderly Patients With mCRPC.

Removing Cancer Survivors From Oncologic Treatment.

In severe cases of renal cell carcinoma, tyrosine kinase inhibitor activity is present.

Finding New Routes to Improve Renal Cell Carcinoma Outcomes.

CAR T-Cell Therapy for Renal Cell Carcinoma: "We're Not There Yet".

Dietary inflammation is associated with the development of urologic cancers.

In infants, laparoscopic robotic pyeloplasty is safe and has a success rate comparable to open surgery.

Medical Bulletin November 30, 2023.

Recommended News For You

RML to develop bone marrow transplantation at Lady Hardinge Medical College in Safdarjung

Achieves a High Disease Control Rate in Head and Neck BCC with Vismodegib-RT Regimen.

AI tool accurately detects tumor location on breast MRI

King Charles' Cancer; COVID Vax Now or Later; Was RFK Jr. a Drug Dealer?

Finding a clue to the origin of treatment-resistant leukemia in kids

Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients

Prostate cancer death risk is higher in late teens and early 20s weight gain.

Recommended Articles For You

Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy

Exploring the Mysteries of MGUS: Uncovering the Causes and Treatments

Unleashing the Power of AI: A Systematic Review of Predictive Biomarker Discovery in Immuno-Oncology

Beyond the Cure: The Emerging Role of Tissue-Agnostic Therapies in Palliative Oncology

Whats more on Hidoc Dr.

Medical Updates

KOL Videos

Surveys

Events

Featured News

Featured Articles

Featured Events

Featured KOL Videos

Quick Links

Verification

Welcome to Hidoc Dr.